The expression of NF-κB p105/p50 and IKKβ was significantly reduced by TanIIA treatment when compared to the AKI model (Figures 4C–E), and the results were confirmed by the NF-κB p105/p50 and IKKβ protein expression measured by Western blot (Figures 4K–M). The gene discussed is NFKB1; the disease is acute kidney injury.